Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Veeva Systems (VEEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Veeva Systems — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.66 (market cap $2.27B), while Veeva Systems trades at $292.57 (market cap $46.12B). The key difference: Veeva Systems is far larger — about 20.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Veeva Systems is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | VEEV | |
|---|---|---|
Market Cap | $2.27B | $46.12B |
Volume | 4,179,659 | 921,537 |
Sector | Health | Technology |
52-Week High | $15.46 | $299.10 |
52-Week Low | $1.39 | $151.43 |
Enterprise Value | $2.14B | $39.03B |
Typical Hold Time | — | 5 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Veeva Systems
Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →
